活体减弱百日咳疫苗对公众健康的潜在益处
1Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019-UMR9017-CIIL - Centre for Infection and Immunity of Lille, Lille, France.
活体减弱鼻疫苗旨在模仿自然免疫力,克服当前疫苗的局限性. 最先进的候选人BPZE1在临床研究中显示出对控制百日咳的前景.
科学领域:
- * 免疫学和疫苗学
- * 微生物学和传染病
- * 公共卫生和流行病学
背景情况:
- *目前的 pertussis 疫苗提供短期的保护,并不能防止 * Bordetella pertussis * 的鼻腔殖民.
- *天然感染* Bordetella pertussis* 诱导了对疾病和感染的持久免疫力.
- * 尽管疫苗接种率很高,但百日咳仍然是流行病,流行病经常发生,这凸显了需要改进策略的必要性.
研究的目的:
- * 审查活体减弱鼻疫苗候选人的现状.
- * 评估开发这些新型疫苗的不同策略.
- *强调最先进的候选疫苗及其临床进展.
主要方法:
- *使用关键词进行文献搜索:"百日咳疫苗"",活"和"减弱".
- * 疫苗开发策略的分析:代谢依赖性,遗传衰减和免疫调节性修饰.
- *对先进的候选疫苗临床试验数据的审查.
主要成果:
- * 只有基因减弱的百日咳疫苗候选人已进入临床试验.
- *BPZE1是主要候选者,已经完成了六项临床研究.
- *BPZE1证明了安全性,诱导了全身和粘膜免疫力,并减少了*B. pertussis*感染.
结论:
- * 活体减弱鼻腔疫苗代表了一种有希望的方法来实现对百日咳的持久免疫力.
- *BPZE1显示出控制百日咳的巨大潜力,这是一个长期存在的全球健康挑战.
- *全球成功采用BPZE1可能是咳根除工作的突破.
更多相关视频
06:32Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
Published on: September 19, 2016
13:47Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens
Published on: May 19, 2020
相关概念视频
Vaccinations
Microorganisms in Medicine and Therapeutics
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Active versus Passive Immunity
Active Immunity
Active immunity refers to the resistance one develops...
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
